Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.43 |
| ▸ | NPY4R | P50391 | 5/20 | 0.39 |
| ▸ | NPY1R | P25929 | 4/20 | 0.39 |
| ▸ | NPY2R | P49146 | 4/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.39 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.38 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.38 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.36 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31349358 | 0.94 | NPY4R (0.40) | PTGS1GSTK1NPY4RNPY1RNPY2R | |
| SCHEMBL29655791 | 0.93 | PTGS1 (0.44) | PTGS1GSTK1NPY4RNPY1RNPY2R | |
| SCHEMBL29655812 | 0.93 | PTGS1 (0.44) | PTGS1GSTK1NPY4RNPY1RNPY2R | |
| SCHEMBL29655840 | 0.93 | PTGS1 (0.44) | PTGS1GSTK1NPY4RNPY1RNPY2R | |
| SCHEMBL29655852 | 0.93 | PTGS1 (0.44) | PTGS1GSTK1NPY4RNPY1RNPY2R | |
| SCHEMBL29533359 | 0.93 | PTGS1 (0.44) | PTGS1GSTK1NPY4RNPY1RNPY2R | |
| SCHEMBL19138 | 0.92 | NOD1 (0.43) | PTGS1GSTK1NPY4RNPY1RNPY2R | |
| SCHEMBL19629051 | 0.92 | NPY4R (0.44) | PTGS1GSTK1NPY4RNPY1RNPY2R | |
| SCHEMBL18132953 | 0.92 | NPY4R (0.44) | PTGS1GSTK1NPY4RNPY1RNPY2R | |
| SCHEMBL13123122 | 0.92 | NOD1 (0.43) | PTGS1GSTK1NPY4RNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0494248-A4 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | — | 1992-08-26 | — | — | EP | claimed |
| EP-0494248-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-07-15 | — | — | EP | claimed |
| WO-1991004746-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1991-04-18 | — | — | WO | claimed |
| US-4952562-A | TREATMENT OF CARDIOVASCULAR DISORDERS | RORER PHARMACEUTICAL CORPORATION (US) | 1990-08-28 | — | — | US | claimed |
| EP-0577775-A4 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES. | RHONE POULENC RORER INT (US) | 1995-01-11 | — | — | EP | disclosed |
| US-5332726-A | Anticoagulant | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1994-07-26 | — | — | US | disclosed |
| EP-0577775-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1994-01-12 | — | — | EP | disclosed |
| WO-1992017196-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-10-15 | — | — | WO | disclosed |
| EP-0494248-A4 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | — | 1992-08-26 | — | — | EP | disclosed |
| EP-0494248-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-07-15 | — | — | EP | disclosed |
| WO-1991004746-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1991-04-18 | — | — | WO | disclosed |
| US-4952562-A | TREATMENT OF CARDIOVASCULAR DISORDERS | RORER PHARMACEUTICAL CORPORATION (US) | 1990-08-28 | — | — | US | disclosed |